Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Issues Arthroscopic Lavage, Debridement Non-Coverage Decisions

This article was originally published in The Gray Sheet

Executive Summary

Local contractors should determine whether coverage for arthroscopic debridement is reasonable and necessary for a patient sub-population presenting with pain and additional symptoms but without severe osteoarthritis, according to CMS

You may also be interested in...



Arthroscopic Knee Surgery Coverage Guidelines Needed For Carriers – AAOS

The American Academy of Orthopaedic Surgeons hopes to meet with CMS to develop guidelines stipulating when local contractors should cover arthroscopic debridement indications for patients with osteoarthritis of the knee, following a 1July 3 non-coverage decision memorandum

Arthroscopic Knee Surgery Coverage Guidelines Needed For Carriers – AAOS

The American Academy of Orthopaedic Surgeons hopes to meet with CMS to develop guidelines stipulating when local contractors should cover arthroscopic debridement indications for patients with osteoarthritis of the knee, following a 1July 3 non-coverage decision memorandum

VA Reviewing Coverage Of Arthroscopic Knee Surgery; NEJM Study Debated

The Veterans Administration plans to complete within the next 90 days an internal review of whether recent study findings warrant continued coverage of arthroscopic knee surgical procedures to alleviate pain and stiffness caused by osteoarthritis

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018654

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel